Skip to content

Bach flower remedies and homoeopathic medicines for treatment of depression

Add-on Bach flower remedies to individualized homoeopathic medicines in mild to moderate depression: Open, randomized pilot trial

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/12/047973
Enrollment
100
Registered
2022-12-08
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F330- Major depressive disorder, recurrent, mild

Interventions

Intervention1: Bach Flower Remedies(BFR) and Individualized Homoeopathic Medicines(IHMs): This arm will receive indicated BFR, to be dispensed in globules no. 30, moistened with 6-8 drops of the indic
dosage and repetition depending upon the individual requirement of the cases. All medicines will be procured from a Good Manufacturing Practice (GMP)-certified firm. Duration of therapy: 3 months. Rou

Sponsors

D N De Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Cases suffering from depression, diagnosed as per DSM-V criteria [13] 2. Mild (HDRS 3. Patients must not have been taking antidepressants or anxiolytic drugs at the time of inclusion. 4. Patients of either sex 5. Age between 18 and 65 years 6. Capability and willingness to give informed consent and to comply with the study procedures 7. Literate patients who can read English, Bengali/or Hindi.

Exclusion criteria

Exclusion criteria: 1. Severe or very severe depression (HDRS > 19); ± suicide attempt 2. Spontaneous improvement by >= 25% in HDRS during the 1-week placebo run-in prior trial enrolment 3. Patients with other psychiatric diseases; e.g., schizophrenia or other psychotic disorders, bipolar affective disorder, schizoaffective disorders, alcohol or other substance abuse, eating disorders, psychosis, mania, hypomania or any other Axis I disorder except panic disorder, personality disorders, history of seizures 4. A clinically significant acute or chronic disease that would hinder regular participation in the study 5. Treatment with antipsychotics, antidepressants, sedatives/hypnotics or mood stabilizers four weeks prior to the screening 6. Complementary or alternative treatment used simultaneously to the study (e.g., acupuncture, phytotherapy, psychotherapy etc.) 7. Homeopathic treatment for any chronic diseases eight weeks prior to study entry 8. Cases suffering from uncontrolled systemic illness or life-threatening infections 9. Self-reported immune-compromised state 10. Pregnant and puerperal women, lactating mothers 11. Substance abuse and/or dependence

Design outcomes

Primary

MeasureTime frame
Hamilton Depression Rating ScaleTimepoint: Baseline and every month, up to 3 months.

Secondary

MeasureTime frame
Becks Depression InventoryTimepoint: Baseline and every month, up to 3 months.

Countries

India

Contacts

Public ContactRajat Kumar Pal

D. N. De Homoeopathic Medical College and Hospital

drrajatkumarpal@gmail.com9433130996

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026